NASDAQ STOCKHOLM HAS APPROVED APPLICATION FOR DE-LISTING
Allenex AB (publ) announced on 20 May 2016 that the company had decided to apply for de-listing of the Allenex share from Nasdaq Stockholm. The application has now been approved.
The last day of trading in the Allenex share will be Wednesday 8 June 2016.
For more information please contact:
Anders Karlsson, CEO Allenex AB, and ph.: +4670-918 00 10, e-mail: firstname.lastname@example.org
Allenex AB discloses the information provided herein pursuant to the Securities Markets Act and /or the Financial Instruments Trading Act. The information was submitted for publication on May 25, 2016, at 08.00 CET. Allenex is a life science-company that develops, manufacture, market and sell products for safer transplants of organs and bone marrow on the global market. Allenex is listed on NASDAQ OMX Stockholm Small Cap (ticker: ALNX). 57 persons are employed in the Allenex group.